期刊文献+

327例海洛因依赖者HCV感染情况分析 被引量:5

The Analysis of HCV Infection in 327 Heroin Addicts
原文传递
导出
摘要 目的:了解不同吸毒方式海洛因依赖者的HCV感染与肝功能异常情况,评估HCV感染和吸毒方式与性别、年限的关系。方法:327例海洛因依赖者入院时均进行血清HCV标志物及丙氨酸氨基转移酶(ALT)检测。结果:327例海洛因依赖者中,HCV感染114例(34.9%),ALT异常41例(12.5%)。在注射方式依赖者中,感染率为62.3%(71/114);HCV感染与性别无关,与注射吸毒年限有关。吸毒年限≤1年的,感染率为36.8%,吸毒年限>1年的,感染率为75.0%。烫吸方式依赖者,感染率为0。ALT异常主要与HCV感染有关。结论:注射方式吸食海洛因是海洛因依赖者感染HCV的主要因素,且感染率与注射吸毒年限呈正相关。 Objective: To survey and analyze the relative factors of epidemiological situation including HCV infection and liver function abnormalities in heron addicts. Methods:327 addicts admitted to inpatient treatment were tested for hepatitis C virus markers and serum ALT related to drug-taking pattern. Results: Among these addicts the rate of HCV infection was 34.9% (71/327), and ALT abnormalities 12.5% (41/327). Sex difference had no correlation with HCV infection . But HCV infection rate was significantly related to drug-taking pattern. The rate of positive reaction among 114 injectors was 62.3% (71/114), but this rate of HCV infection among 213 snorts seemed zero. ALT abnormalities were significantly correlated with HCV infection. Conclusion: HCV infection was positively related with drug-taking pattern and duration of injection.
机构地区 浙江省青春医院
出处 《中国药物滥用防治杂志》 CAS 2005年第3期153-154,共2页 Chinese Journal of Drug Abuse Prevention and Treatment
关键词 海洛因依赖 HCV感染 流行病学 肝功能异 Heroin addict Hepatitis C virus ALT
  • 相关文献

参考文献4

二级参考文献31

  • 1庄兰英.新媒体视角下电视新闻采编策划特点分析[J].新闻研究导刊,2020,0(5):9-9. 被引量:6
  • 2骆抗先.乙型肝炎-基础与临床[M].北京:人民卫生出版社,1997.453-464.
  • 3葛向华,王俊升,齐建民,胡金弟,葛剑文,徐庆霞.丙型肝炎70例传播途径分析[J].人民军医,1997,40(5):278-278. 被引量:2
  • 4Camma C, Bruno S, Schepis F, et al. Retreatment with interferon plus ribavirin of chronic hepatitis C non- responders to interferon monotherapy: a meta- analysis of individual patient data[ J ]. Gut, 2002,51:864-869.
  • 5Papatheodoridis GV, Papadimitropoulos VC, Hsdziyannis SJ. Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus- reated cirrhosis: a meta- analysis[J] .Aliment Pnarmaool Ther, 2001,15:689- 698.
  • 6Kjaergard LL, Krogsgaard K, Gluud C. Interfern alfa with or without ribavirin for chronic hepatitis C: systematic review of randonmised trials[J].BMJ, 2001,323:1151 - 1155.
  • 7Alberti A, Benvegnu L. Management of hepatitis[J] .J Hepatol, 2003,38(Suppl1): S1014 - S1 18.
  • 8Poynard T, MdHutchison J, Davis GL, et al. Impact of interferon alfa - 2b and ribavirin on progression of liver fibrosiis in patients with chronic hepatitis C[J].Hepatology, 2000,32:1131 - 1137.
  • 9Booth JCL, O' Grady J, Neuberger J. Clinical guidelines on the mangement of hepatitis C[J]. Gut, 2001, 49(Suppl I ): il - i12.
  • 10Chander G, Sulkowski MS, Jenckes MW, et al. Treatment of chronic hepatitis C: a systemic review[J]. Hepatology, 2002, 36(5 Suppl 1 ):S135 - S144.

共引文献747

同被引文献19

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部